Azithromycin impact on neutrophil oxidative metabolism depends on exposure time

Inflammation

Volumn 22, Issue 2, 1998, Pages 191-201

  Levert, H ^a   Gressier, B ^a,b   Moutard, I ^a   Brunet, C ^a   Dine, T ^a   Luyckx, M ^a   Cazin, M ^a   Cazin, J C ^a  

^a UNIV LILLE   (France)

^b Centre Hospitalier d'Armentieres   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; MACROLIDE; PHORBOL 13 ACETATE 12 MYRISTATE;

AEROBIC METABOLISM; ARTICLE; DOSE RESPONSE; HUMAN; HUMAN CELL; LEUKOCYTE METABOLISM; NEUTROPHIL; NORMAL HUMAN; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; AZITHROMYCIN; CELL-FREE SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KINETICS; L-LACTATE DEHYDROGENASE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PHAGOCYTOSIS; REACTIVE OXYGEN SPECIES; STAPHYLOCOCCUS AUREUS; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE;

STAPHYLOCOCCUS AUREUS;

EID: 0031967280     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022340107017     Document Type: Article

References (35)

1. .- -forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function. Bioch. Bioph. Acta 853:65-89.
2. WEISS, S. J. 1989. Tissue destruction by neutrophils. New Engl. J. Med. 320:365-376.
3. THELEN, M., B. DEWALD, and M. BAGGIOLINI. 1993. Neutrophil signal transduction and activation of the respiratory burst. Phys. Rev. 73:797-821.
4. ROOS, D. 1991. The respiratory burst of phagocytic leucocytes. Drug. Invest. 3:48-53.
5. LABRO, M. T. and J. EL BENNA. 1991. Effects of anti-infectious agents on polymorphonuclear neutrophils. Eur. J. Clin. Microbiol. Infect. Dis. 10:124-131.
6. JAESCHKE, H. 1995. Mechanisms of oxidant stress-induced acute tissue injury. P.S.E.B.M. 209:104-111.
7. HAND, W. L., D. L. HAND, and N. L. KING-THOMPSON. 1990. Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 34:863-870.
8. MOUTARD, I., B. GRESSIER, C. BRUNET, T. DINE, M. LUYCKX, M. CAZIN, and J. C. CAZIN. 1997. In Vitro interaction between dirithromycin or its metabolite, erythromycylamine, and oxidative polymorphonuclear metabolism J. Antibiot. 50:53-57.
9. LABRO, M. T., and J. EL BENNA. 1990. Synergistic bactericidal interaction of josamycin with human neutrophils in vitro. J. Antimicrob. Chemother. 26:515-524.
10. VAN DEN BROEK, P. J. 1989. Antimicrobial drugs, microorganisms, and phagocytes. Rev. Infect. Dis. 11:213-245.
11. PLEWIG, G., and E. SCHÖPF. 1975. Anti-inflammatory effects of antimicrobial agents: an in vivo study. J. Invest. Derm. 65:532-536.
12. AGEN, C., R. DANESI, C. BLANDIZZI, M. COSTA, B. STACCHINI, P. FAVINI, and M. DEL TACCA. 1993. Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected role. Agents Actions 38:85-90.
13. 2 activation in human neutrophils. Differential actions of diacylglycerols and alkylacylglycerols in priming cells for stimulation by N-formyl-Met-Leu-Phe. J. Biol. Chem. 263:16787-16795.
14. CURNUTTE, J. T., R. W. ERICKSON, J. DING, and J. A. BADWEY. 1994. Reciprocal interactions between protein kinase C and components of the NADPH oxidase complex may regulate superoxide production by neutrophils stimulated with a phorbol ester. J. Biol. Chem. 269:10813-10819.
15. PASCUAL, A., G. LOPEZ-LOPEZ, J. ARAGON, and E. J. PEREA. 1990. Effect of azithromycin, roxithromycin and erythromycin on human polymorphonuclear leukocyte function against Staphylococcus aureus. Chemotherapy. 36:422-427.
16. PASCUAL, A., M. CARMEN CONEJO, I. GARCIA, and E. J. PEREA. 1995. Factors affecting the intracellular accumulation and activity of azithromycin. J. Antimicrob. Chemother. 35:85-93.
17. MAC DONALD, P. J., and H. PRUUL. 1991. Phagocyte uptake and transport of azithromycin. Eur. J. Clin. Microb. Infect. Dis. 10:828-833.
18. SCHENTAG, J. J., and C. H. BALLOW. 1991. Tissue directed pharmacokinetics. Am. J. Med. 91:5S-11S.
19. KIRST, H. A., and G. D. SIDES. 1989. New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy. Antimicrobial. Agents Chemother. 33:1419-1422.
20. CABANIS, A., B. GRESSIER, S. LEBEGUE, C. BRUNET, T. DINE, M. LUYCKX, M. CAZIN, and J. C. CAZIN. 1994. A rapid density gradient technique for separating polymorphonuclear granulocytes. APMIS 102:109-121.
21. SRINIVAS, V. K., C. M. HABIBULLAH, Q. AYESHA, S. I. HASSAN, U. R. KHALEEL, K. REHMAN, and S. MOHSINS. 1993. Lactate dehydrogenase: a marker of cellular integrity. Meth. Find. Exp. Clin. Pharmacol. 15:709-713.
22. ARUOMA, O. I., B. HALLIWELL, B. M. HOEY, and J. BUTLER. 1989. The antioxidant action of N-acetylcystein: its reaction with hydrogen peroxide, hydroxyl radical, superoxide and hypochlorous acid. Free Rad. Biol. Med. 6:593-597.
23. KHALFI, F., B. GRESSIER, C. BRUNET, T. DINE, M. LUYCKX, M. CAZIN, and J. C. CAZIN. 1996. Involvement of extracellular calcium in the release of elastase and the human neutrophils oxidative burst. Cell. Mol. Biol. 42:1211-1218.
24. COHEN, H. J., and M. E. CHOVANIEC. 1978. Superoxide generation by digitonin stimulated guinea pig granulocytes. A basis for continuous assay for monitoring superoxide production and for the study of the activation of the generating system. J. Clin. Invest. 61:1081-1087.
25. CABANIS, A., B. GRESSIER, C. BRUNET, T. DINE, M. LUYCKX, M. CAZIN, and J. C. CAZIN. 1996. Effect of the protein kinase C inhibitor GF109203X on elastase release and respiratory burst of human neutrophils. Gen. Pharmac. 27:1409-1414.
26. PROKESCH, R. C., and W. L. HAND. 1982. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 21:373-380.
27. GLADUE, R. P., G. M. BRIGHT, R. E. ISAACSON, and M. F. NEWBORG. 1989. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob. Agents Chemother. 33:277-282.
28. WILDFEUER, A., I. REISERT, and H. LAUFEN. 1993. Uptake and subcellular distribution of azithromycin in human phagocytic cells. Arzneim. Forsch. 43:484-486.
29. WILDFEUER, A., H. LAUFEN, D. MÜLLER-WENING, and O. HAFERKAMP. 1989. Interaction of azithromycin and human phagocytic cells. Arzneim. Forsch. 39:755-758.
30. LABRO, M. T., J. EL BENNA, and H. ABDELGHAFFAR. 1993. Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin. J. Antimicrob. Chemother. 31:51-64.
31. JOONE, G. K., E. J. VAN RENSBURG, and R. ANDERSON. 1992. Investigation of the in vitro uptake, intraphagocytic biological activity and effects on neutrophil superoxide generation of dirithromycin compared with erythromycin. J. Antimicrob. Chemother. 30:509-523.
32. ANDERSON, R., A. J. THERON, and C. FELDMAN. 1996. Membrane-stabilizing, antiinflammatory interactions of macrolides with human neutrophils. Inflammation 20:693-705.
33. GAUDRY, M., C. COMBADIERE, C. MARQUETTY, and J. A. HAKIM. 1990. Comparison of priming effect of phorbolmyristate acetate and phorbol dibutyrate on fMLP induced oxidative burst in human neutrophils. Immunopharmacol. 20:45-56.
34. KESSELS, G. C. R., D. ROOS, and A. J. VERHOEVEN. 1991. FMet-Leu-Phe-induced activation of phospholipase D in human neutrophils. J. Biol. Chem. 34:23152-23156.
35. PANTEIX, G., B. GUILLAUMOND, R. HARF, A. DESBOS, V. SAPIN, M. LECLERCQ, and M. PERRIN-FAYOLLE. 1993. In-vitro concentration of azithromycin in human phagocytic cells. J. Antimicrob. Chemother. 31:1-4.